China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 5% in First Three Quarters of 2023

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 1.1 billion yuan in the first three quarters of 2023, up 5% year-on-year.

Meanwhile, the company posted 7.5 billion yuan in revenue, up 5.4% year-on-year.

At the end of the reporting period, it had 15 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 23.3%.